Connecting Visionaries, Innovators, and Industry Leaders
The conference programme brings together industry leaders, researchers, investors, policymakers, and innovators to explore the opportunities, challenges, and breakthroughs shaping the future of biotechnology. Through inspiring keynote presentations, expert-led panel discussions, and industry-focused sessions, attendees gain valuable insights into emerging trends, transformative technologies, and evolving market dynamics. A platform for collaboration, knowledge exchange, and strategic partnerships that accelerate innovation and commercial growth across the biotechnology ecosystem.
What’s On the Agenda?
The conference brings together thought leaders and pioneers to share insights, spark ideas, and shape the future of the life sciences industry.
Biopharma, Vaccines & Biomanufacturing
Gene & Cell Therapy + Regenerative Medicine
Diagnostics, Precision Medicine & Digital Health
AI, Bioinformatics & Clinical Development
Artificial Intellegence & Bioinformatics
Scaling Gene & Cell Therapies
Revolutionising Biomanufacturing
Vaccine Innovation and Global Health
Clinical Trials of the Future
Who Should Attend?
Biotech and
Pharma Companies
Clinical &
Healthcare Decision-Makers
Technology &
Lab Solution Providers
Investors, policymakers, and
Regulators
Academic
Researchers
Startups and
Entrepreneurs
Hospital Networks &
Procurement Specialists
Science Parks &
Innovation Hubs
Government Bodies &
Industry Associations
Why
Attend?
Gain Actionable Insights
Learn from global experts and thought leaders across all major biotech sectors.
Hands-On Learning
Participate in workshops, live demonstrations, and interactive sessions.
Expand Your Network
Connect with 4,000+ attendees and 1,800+ organisations from around the world.
Shape the Future
Be part of conversations and collaborations that will define the next era of biotechnology.
Frequently Asked Questions
What does a Delegate ticket to the LBS26 conference include?
A Delegate ticket gives access to the full conference programme; keynote presentations, panel discussions, and industry-focused sessions across four themes: Biopharma, Vaccines & Biomanufacturing; Gene & Cell Therapy + Regenerative Medicine; Diagnostics, Precision Medicine & Digital Health; and Al, Bioinformatics & Clinical Development.
Who should attend the LBS26 conference?
The conference is designed for biotech and pharma companies, clinical and healthcare decision-makers, technology and lab solution providers, investors, policymakers and regulators, academic researchers, startups and entrepreneurs, hospital networks and procurement specialists, science parks and innovation hubs, and government bodies and industry associations.
How many people attend the LBS26 conference?
The conference page states attendees can expect to connect with 4,000+ attendees and 1,800+ organisations from around the world.
What can I expect to gain from attending the LBS26 conference?
Four things: actionable insights from global experts across all major biotech sectors, hands-on learning through workshops and live demonstrations, an expanded network of 4,000+ attendees, and early visibility into conversations shaping biotechnology's next era.